{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-114467","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.134029+00:00","generated_at":"2026-05-30T14:36:59.160728+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Iterum receives Nasdaq delisting notice, hearing set for Nov 21 on equity compliance","bullets":["Nasdaq notified Iterum on Oct 1 of delisting for failing to meet $2.5M stockholders' equity requirement after Sep 30 extension deadline.","Company requested hearing; Nasdaq Hearings Panel will consider appeal on November 21, 2024.","Trading of ITRM ordinary shares continues on Nasdaq Capital Market pending hearing outcome.","Panel may grant compliance extension up to March 31, 2025, but no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-114467","json":"https://secwatch.observer/filing/0000950170-24-114467.json","markdown":"https://secwatch.observer/filing/0000950170-24-114467.md","text":"https://secwatch.observer/filing/0000950170-24-114467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024114467/0000950170-24-114467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024114467/itrm-20241009.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:36:59.160728+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}